Keyphrases
Prostate Cancer
78%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
56%
Prostate Cancer Risk
48%
Enzalutamide
43%
Susceptibility Loci
42%
Multiparametric MRI (mpMRI)
42%
Abiraterone Acetate
40%
Confidence Interval
34%
Penis
32%
Prevalence Factors
28%
Association Analysis
28%
Predictive Factors
28%
Metabolic Changes
28%
Brachytherapy
28%
Quality of Life Changes
28%
Neglected Sexual Side Effects
28%
Antibiotic Prophylaxis
28%
Transperineal Prostate Biopsy
28%
Nave
28%
Randomized Clinical Trial
28%
Prednisone
25%
Prostate Biopsy
23%
Clinically Significant Prostate Cancer
22%
Herlev
21%
Orgasm
21%
Fine Mapping
21%
Health-related Quality of Life
19%
Prostate
18%
Polygenic Risk Score
17%
Transrectal Biopsy
17%
Low-dose-rate Brachytherapy
16%
Biopsy Naïve
16%
Prebiopsy
16%
Denmark
16%
Predictive Biomarker
16%
Sensory Disturbance
16%
Localized Prostate Cancer
16%
Diagnostic Accuracy
16%
Gleason Score 7
16%
University Hospital
15%
Ratcheting
14%
Aerator
14%
Radiation Therapy for Prostate Cancer
14%
Testicular Microlithiasis
14%
Third-line Therapy
14%
Utility Study
14%
Cabazitaxel
14%
Acute Epididymitis
14%
Cross-sectional Observational Study
14%
Corpus Cavernosum
14%
Medicine and Dentistry
Prostate Cancer
100%
Biopsy
63%
Magnetic Resonance Imaging
54%
Prostate Biopsy
44%
Side Effect
36%
Phallus
32%
Brachytherapy
28%
Castration Resistant Prostate Cancer
28%
Antibiotic Prophylaxis
28%
Prevalence
28%
Prostate Specific Antigen
22%
Orgasm
21%
Malignant Neoplasm
19%
Testis Cancer
17%
Transrectal Ultrasonography
16%
Diagnostic Accuracy
16%
Enzalutamide
15%
Cancer Susceptibility
14%
Carcinoma in Situ
14%
Nuclear Magnetic Resonance
14%
Cabazitaxel
14%
Quality of Life
14%
Prednisolone
14%
Low-Dose-Rate Brachytherapy
14%
Epididymitis
14%
Corpus Cavernosum Penis
14%
Abiraterone
14%
Observational Study
14%
External Beam Radiotherapy
14%
Thrombosis
14%
Abiraterone Acetate
12%
Pivmecillinam
10%
Amoxicillin/Clavulanic Acid
10%
Odds Ratio
9%
Erectile Dysfunction
9%
Cancer Therapy
8%
Androgen Deprivation Therapy
7%
Testis Biopsy
7%
Precancerous Condition
7%
Parenchyma
7%
Testis Atrophy
7%
Local Anesthesia
7%
Contralateral
7%
Urine Incontinence
7%
Antibiotic Therapy
7%
Anejaculation
7%
Progression Free Survival
6%
Overall Survival
6%
Clinical Trial
6%
Adipose Tissue
5%